A Study of Efficacy and Safety of TLL-018 in CSU Participants

Clinical trial NCT06396026 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06396026
Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria

Start date: 2024-03-27
Primary completion: 2025-10-23
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.